DTRT Health Acquisition - Warrants (31/08/2029) Common Stock

The latest common stock for DTRTW is $470M as of September 2022. That compares with $230M in the prior-year period — up 100.9% year over year. Investors often review this figure alongside DTRT Health Acquisition - Warrants (31/08/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DTRTW's common stock moved from $230M to $470M — a 100.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DTRT Health Acquisition - Warrants (31/08/2029)'s operating scale or balance-sheet position.

A common stock figure of $470M for DTRTW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DTRTW's common stock ($470M), review year-over-year change from $230M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.